In addition to the ones you mentioned, I expect we'll get a K-OC cohort 1 update this quarter. So we'll have:
Q3
1. B-OM Interim
2. P Interim
3. K-OC Cohort 1
Q4
1. B-OM Top-line
2. P Top-line
3. K-OC Cohort 2
Meanwhile, partnership negotiation for B-UP could be underway.
Q3
1. B-OM Interim
2. P Interim
3. K-OC Cohort 1
Q4
1. B-OM Top-line
2. P Top-line
3. K-OC Cohort 2
Meanwhile, partnership negotiation for B-UP could be underway.
4
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links